NCT00287521已完成2 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 87
- 试验地点
- 1
- 主要终点
- Mean intra-ocular pressure (IOP) change at Day 28 from baseline (Day 0)
研究概览
简要总结
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with open-angle glaucoma (with ot without pseudoexfoliation or pigment dispersion component) or ocular hypertension
- •Other protocol-defined inclusion criteria may apply.
排除标准
- •Other protocol-defined exclusion criteria may apply.
研究组 & 干预措施
AL-37807 Suspension
Experimental
干预措施: AL-37807 Ophthalmic Suspension, 1.0% (Drug)
Xalatan
Active Comparator
干预措施: Latanoprost, 0.005% (Xalatan) (Drug)
AL-37807 Vehicle
Placebo Comparator
干预措施: AL-37807 Vehicle (Other)
Timolol Maleate
Experimental
干预措施: Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% (Drug)
结局指标
主要结局
Mean intra-ocular pressure (IOP) change at Day 28 from baseline (Day 0)
时间窗: Day 28
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314158Alcon Research523
已完成
3 期
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314171Alcon Research437
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00293761Alcon Research109
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00293787Alcon Research156
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00293800Alcon Research173